Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersPulmonary Disease Physician in Atlanta, GA
NPI: 1104935469Primary Practice Location
PIEDMONT FAYETTE HOSPITAL
1255 Highway 54 W, Fayetteville, GA
Primary Employer
Piedmont Clinic
piedmontclinic.org
HQ Phone
Get M.D. Seth's Phone Numberphone_androidMobile
Get M.D. Seth's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardGA State Medical License
WV State Medical License
GA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 144 | 272 |
| 2 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 80 | 106 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 80 | 138 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 65 | 91 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 46 | 46 |
Authors: Vin Tangpricha, Patricia Joseph, Thomas Ziegler, James Chmiel
Journal: Contemp Clin Trials Commun
Publication Date: 2017-03-09
A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11 years with cystic fibrosis.
Authors: Neil Ahluwalia, Patrick Flume, James Chmiel
Publication Date: 2019-05-14
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation.
Lead Sponsor: James Reynolds
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Case Western Reserve University, University Hospitals Cleveland Medical Center
Intervention / Treatment: DRUG: GSNO
Lead Sponsor: Seattle Children's Hospital
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Cystic Fibrosis Foundation, CF Therapeutics Development Network Coordinating Center
Intervention / Treatment: DRUG: inhaled tobramycin, DRUG: azithromycin, DRUG: placebo (for azithromycin)
